Analysis of synthetic peptides in the laboratory

Biopharmaceutical services Recombinant protein analysis
More than 140 people
More than 140 people at your service
5200 m² laboratory
5200 m² laboratory + 99% of services are provided in-house
Accredited laboratory
Accredited laboratory COFRAC ISO 17025

You wish to carry out an analysis of synthetic peptides present in your matrices or finished products

What is a synthetic peptide?

A synthetic peptide is a chain of amino acids (like proteins, but shorter) that is artificially made in a laboratory, usually by chemical synthesis rather than biological means.

FILAB offers you the analysis of synthetic peptides

Peptides are versatile molecules used in various sectors such as pharmaceuticals and cosmetics. Their specificity and effectiveness allow them to play a key role in the development of new treatments or the improvement of skin care. This diversity of applications underscores the considerable potential of peptides and the importance of continuing research in this field.

Our analysis services on synthetic peptides

Purity control

Search for impurities and contaminants

Regulatory support for your quality files (ICH, pharmacopoeias, ISO, etc.)

Characterization of active ingredients

Checking the molecular mass and expected sequence

Stability studies (thermal, oxidative, hydrolytic stress)

Our technical means for the analysis of synthetic peptides

Mass spectrometry

HS-GC/MS

MALDI-TOF

LC-QTOF-MS

HPLC-MS et HPLC-MS/MS (Orbitrap)

Evaluating your synthetic peptides for the US market

We support manufacturers developing synthetic peptides based on already approved rDNA peptides, such as glucagon, liraglutide, nesiritide, teriparatide, or teduglutide.

According to FDA guidance, these products can be submitted as ANDAs (Abbreviated Application) rather than NDAs (Full Application), thereby reducing time and cost to market.

ANDA/NDA: placing on the American market

Indeed, manufacturers often find themselves faced with a question: should their synthetic peptide-based drug be submitted as an ANDA or as an NDA?

An ANDA (Abbreviated New Drug Application) is a registration procedure with the FDA (Food and Drug Administration, USA) allowing a generic drug to be placed on the market.
An NDA – New Drug Application is the official file submitted to the FDA (Food and Drug Administration, USA) to obtain marketing authorization (MA) for an innovative drug.

Thanks to our expertise in peptide mapping, characterization, and sequencing, FILAB helps you:

  • Ensure the equivalence of your synthetic peptide with the reference product
  • Prepare a robust dossier that complies with FDA requirements

Why analyze your synthetic peptides?

Synthetic peptides are widely used in the pharmaceutical, cosmetic, and biotechnology sectors. Their efficacy and safety depend directly on their purity, sequence, and stability.
Reliable analysis helps ensure the quality of your products, meet regulatory requirements, and accelerate your R&D or industrial projects.

Why choose FILAB for synthetic peptide analysis

  • Recognized expertise in chemical and biochemical analysis.

  • Independent and impartial results.

  • Personalized support: from one-off analyses to the implementation of monitoring programs.

  • Responsiveness thanks to an integrated laboratory located on a single site.

FAQ

Why analyze a synthetic peptide?

Because its purity, sequence, and stability determine its efficacy and safety. Analysis ensures that it meets expected specifications and complies with regulatory standards.

What parameters can be checked during an analysis?
  • Chemical purity
  • Exact sequence (peptide identity)
  • Molecular mass
  • Impurity profile (truncations, unintentional modifications)
  • Stability under stress (temperature, oxidation, hydrolysis)
  • Concentration and dosage
What are the regulatory issues?
  • Peptides intended for the pharmaceutical sector must meet ICH and pharmacopoeial (USP, Ph. Eur.) requirements.

  • In the cosmetics sector, they must comply with Regulation (EC) No. 1223/2009.

  • Traceability and analytical documentation are essential for marketing.

What is the difference between a crude peptide and a purified peptide?
  • A crude peptide still contains impurities related to synthesis.
  • A purified peptide has undergone purification steps (often preparative HPLC) and achieved a higher level of purity (>95% depending on the application).
The filab advantages
A highly qualified team
A highly qualified team
Responsiveness in responding to and processing requests
Responsiveness in responding to and processing requests
A COFRAC ISO 17025 accredited laboratory
A COFRAC ISO 17025 accredited laboratory
(Staves available on www.cofrac.com - Accreditation number: 1-1793)
A complete analytical park of 5,200m²
A complete analytical park of 5,200m²
Tailor-made support
Tailor-made support
Video debriefing available with the expert
Video debriefing available with the expert
Anaïs DECAUX Customer Support Manager
Ask for your quote